Cell Line Development Using the Beacon® Platform
Summary: Speed and efficiency are top priorities for companies looking to develop a clonal cell line for drug substance manufacturing. Catalent was the first CDMO in North America to adopt the Berkeley Lights Beacon® platform for cell line development, leveraging the Beacon platform and Catalent’s GPEx® cell line development technology to accelerate timelines and increase productivity.